Trial Profile
A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2021
Price :
$35
*
At a glance
- Drugs Crisaborole (Primary)
- Indications Seborrhoeic dermatitis
- Focus Proof of concept; Therapeutic Use
- 01 Oct 2021 Status changed from recruiting to completed.
- 16 Jun 2020 Planned End Date changed from 1 Sep 2020 to 1 Mar 2021.
- 16 Jun 2020 Planned primary completion date changed from 1 May 2020 to 1 Dec 2020.